Latest news in cancer
CAR T-Cell therapy in Mumbai, India
CAR T-cell therapy, an advanced cancer treatment, is now available in Mumbai, offering hope to those suffering from some types of blood cancers. This therapy...
LungVax: Lung cancer vaccine
LungVax is an innovative lung cancer vaccine designed to stimulate the immune system to target and destroy cancer cells. It is engineered to enhance the body's...
Successful CRISPR Gene Therapies in Practice: Case Studies
Presenting real-world examples of CRISPR gene therapies that have been successfully implemented, highlighting patient outcomes and lessons...
Gamma Delta (γδ) T cells as a potential treatment for glioblastoma
Introduction Despite being a minority among T cells, γδ T cells play crucial roles in immune defense against infections and in the suppression of...
World-first lung cancer vaccine trials started in seven countries
The lung cancer vaccine clinical trial had been recently launched in seven countries, including the United States, Japan, and Spain, which could prove to be an...
Lazertinib with amivantamab-vmjw is approved by the USFDA for non-small lung cancer
August 2024: The Food and Drug Administration (FDA) has granted approval for the use of lazertinib (Lazcluze, Janssen Biotech, Inc.) in combination with...
Neoadjuvant/adjuvant durvalumab is approved by the USFDA for resectable non-small cell lung cancer
The USFDA approved neoadjuvant/adjuvant durvalumab for the treatment of patients with resectable NSCLC. It marked a turning point in cancer treatment by...
The FDA has granted approval for the use of vorasidenib in the treatment of Grade 2 astrocytoma or oligodendroglioma in patients having a specific IDH1 or IDH2 mutation
The FDA has granted approval for the use of vorasidenib in treating Grade 2 astrocytoma or oligodendroglioma in patients with a specific IDH1 or IDH2 mutation....
The FDA has granted accelerated approval to afamitresgene autoleucel for the treatment of unresectable or metastatic synovial sarcoma
The FDA has granted accelerated approval to afamitresgene autoleucel, a CAR T-cell therapy, for the treatment of unresectable or metastatic synovial sarcoma in...
The FDA has broadened the indication for dostarlimab-gxly to include the treatment of endometrial cancer in combination with chemotherapy
Dostarlimab-gxly is now indicated for the treatment of endometrial cancer in association with chemotherapy. The broader indication provides that it will be...
The FDA has granted approval for the use of daratumumab and hyaluronidase-fihj in combination with bortezomib, lenalidomide, and dexamethasone for the treatment of multiple myeloma
The FDA has granted approval for the utilization of daratumumab and hyaluronidase-fihj in conjunction with bortezomib, lenalidomide, and dexamethasone as a...
The FDA has granted expedited approval to epcoritamab-bysp for the treatment of R/R follicular lymphoma
Epcoritamab-bysp has received accelerated approval from the FDA for the treatment of relapsed or refractory (R/R) follicular lymphoma, a subtype of non-Hodgkin...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.